EUVIMEDEUVIMED entdecken
Multizentrische Studie

Long-Term Systemic Use of Calcium Channel Blockers and Incidence of Primary Open-Angle Glaucoma

Kiana Tavakoli, Sophia Sidhu, Bharanidharan Radha Saseendrakumar, Robert N Weinreb, Sally L Baxter

Ophthalmology Glaucoma · 2024

DOI: 10.1016/j.ogla.2024.06.003 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ophthalmology Glaucoma, 2024. Verfasst von Kiana Tavakoli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Ophthalmology Informatics and Data Science and Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Instit…. Hauptthemen laut MEDLINE: Glaucoma, Open-Angle, Calcium Channel Blockers, Intraocular Pressure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NIH HHS, NEI NIH HHS, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the association between the systemic use of calcium channel blockers (CCBs) and primary open-angle glaucoma (POAG) using a diverse nationwide dataset. DESIGN: Retrospective cohort study. SUBJECTS: 213 424 individuals aged 40 years and older in the National Institutes of Health All of Us dataset, notable for its demographic, geographic, and medical diversity and inclusion of historically underrepresented populations. Patients with a diagnosis of POAG prior to use of any kind of antihypertensive medication were excluded. METHODS: Bivariate and multivariable regression analyses were performed to evaluate associations between CCB use and POAG. Calcium channel blocker use was further divided into exposure to dihydropyridine CCBs and nondihydropyridine CCBs, and subgroup analyses were performed using chi-square and Fisher tests. MAIN OUTCOME MEASURES: Diagnosis of POAG. RESULTS: Within our cohort, 2772 participants (1.3%) acquired a diagnosis of POAG, while 210 652 (98.7%) did not. Among patients who developed POAG, the mean age was 73.3 years, 52.5% were female, and 48.2% identified as White. Among patients with POAG, 32.6% used 1 or more CCB, 28.2% used a dihydropyridine CCB, and 2.2% used a nondihydropyridine CCB. In bivariate analysis, use of any CCBs was associated with an increased risk of POAG (odds ratio [OR]: 1.29, 95% confidence interval [CI]: 1.27-1.31, P < 0.001). In multivariable analysis adjusting for age, gender, race, ethnicity, and comorbidities such as diabetes, hyperlipidemia, and hypertension, use of any CCBs remained associated with an increased risk of developing POAG (OR: 1.52, 95% CI: 1.33-1.74, P < 0.001). When stratified by type of CCB, the use of dihydropyridine CCBs (OR: 1.31, 95% CI: 1.14-1.50, P < 0.001) was associated with increased POAG risk. CONCLUSIONS: Use of dihydropyridine CCBs was associated with a significantly higher risk of developing POAG, both before and while adjusting for demographic factors and comorbid medical conditions. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glaucoma, Open-AngleCalcium Channel BlockersIntraocular PressureHumansFemaleMaleRetrospective StudiesIncidenceAgedUnited StatesMiddle AgedFollow-Up StudiesRisk FactorsAdult

Stichwörter der Autor:innen

AntihypertensivesBig dataCalcium channel blockersHypertensionPrimary open-angle glaucoma

Substanzen

Calcium Channel Blockers

Autor:innen und Institutionen

  • Division of Ophthalmology Informatics and Data Science and Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California; Divisio…
  • Division of Ophthalmology Informatics and Data Science and Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California.

Förderung

  • NIH HHS
  • NEI NIH HHS
  • NIMHD NIH HHS
  • US Government National Institutes of Health
  • National Eye Institute
  • National Institute on Minority Health and Health Disparities
  • Research to Prevent Blindness

Zitieren

APA

Tavakoli, K., Sidhu, S., Radha Saseendrakumar, B., Weinreb, R. N., & Baxter, S. L. (2024). Long-Term Systemic Use of Calcium Channel Blockers and Incidence of Primary Open-Angle Glaucoma. Ophthalmology Glaucoma. https://doi.org/10.1016/j.ogla.2024.06.003

Vancouver

Tavakoli K, Sidhu S, Radha Saseendrakumar B, Weinreb RN, Baxter SL. Long-Term Systemic Use of Calcium Channel Blockers and Incidence of Primary Open-Angle Glaucoma. Ophthalmology Glaucoma. 2024. doi:10.1016/j.ogla.2024.06.003

BibTeX
@article{Tavakoli2024,
  author = {Tavakoli, Kiana and Sidhu, Sophia and Radha Saseendrakumar, Bharanidharan and Weinreb, Robert N and Baxter, Sally L},
  title = {Long-Term Systemic Use of Calcium Channel Blockers and Incidence of Primary Open-Angle Glaucoma},
  journal = {Ophthalmology Glaucoma},
  year = {2024},
  doi = {10.1016/j.ogla.2024.06.003}
}
Kostenlos starten →